Mediwelcome Healthcare Management & Technology (HKSE:02159) Altman Z2-Score: 1.86 (As of Jul. 22, 2026) — 62% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02159 Mediwelcome Healthcare Management & Technology Inc HKSE:02159
54 GF Score
Price HK$1.62
GF Value HK$0.70
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Mediwelcome Healthcare Management & Technology Altman Z2-Score?

Mediwelcome Healthcare Management & Technology HKSE:02159 +0.62% 54 Altman Z2-Score is 1.86 as of Jul. 22, 2026, which is 62% below its 10-year median of 4.85. GuruFocus rates HKSE:02159 with a GF Score™ of 54/100 and a GF Value™ of HK$0.70 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 674 Healthcare Providers & Services companies, Mediwelcome Healthcare Management & Technology ranks worse than 54.01% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Mediwelcome Healthcare Management & Technology has a Altman Z2-Score of 1.86, indicating it is in Grey Zones. This implies that Mediwelcome Healthcare Management & Technology is in some kind of financial stress. If it is below 1.1, the company may face bankrupcy risk.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Mediwelcome Healthcare Management & Technology's Altman Z2-Score or its related term are showing as below:

HKSE:02159' s Altman Z2-Score Range Over the Past 10 Years
Min: -1.9   Med: 4.85   Max: 8.71
Current: 1.86

During the past 9 years, Mediwelcome Healthcare Management & Technology's highest Altman Z2-Score was 8.71. The lowest was -1.90. And the median was 4.85.


Mediwelcome Healthcare Management & Technology  (HKSE:02159) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Mediwelcome Healthcare Management & Technology Altman Z2-Score Related Terms


Mediwelcome Healthcare Management & Technology Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Mediwelcome Healthcare Management & Technology's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mediwelcome Healthcare Management & Technology Altman Z2-Score Chart

Mediwelcome Healthcare Management & Technology Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only 8.71 2.71 -0.53 -1.90 1.86

Mediwelcome Healthcare Management & Technology Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.53 0.00 -1.90 0.00 1.86

HKSE:02159 vs VEEV, BTSG, TEM: Altman Z2-Score Comparison

For the Health Information Services subindustry, Mediwelcome Healthcare Management & Technology's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mediwelcome Healthcare Management & Technology Altman Z2-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mediwelcome Healthcare Management & Technology's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Mediwelcome Healthcare Management & Technology's Altman Z2-Score falls into.


HKSE:02159
54GF Score
Mediwelcome Healthcare Management & Technology Inc HKSE:02159
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mediwelcome Healthcare Management & Technology Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Mediwelcome Healthcare Management & Technology's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.386+3.26*-0.7192+6.72*0.0442+1.05*1.3072
=1.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was HK$210.4 Mil.
Total Current Assets was HK$172.5 Mil.
Total Current Liabilities was HK$91.2 Mil.
Retained Earnings was HK$-151.4 Mil.
Pre-Tax Income was HK$7.7 Mil.
Interest Expense was HK$-1.6 Mil.
Total Liabilities was HK$94.0 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(172.464 - 91.235)/210.436
=0.386

X2=Retained Earnings/Total Assets
=-151.353/210.436
=-0.7192

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(7.713 - -1.589)/210.436
=0.0442

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(122.904 - 0)/94.021
=1.3072

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Mediwelcome Healthcare Management & Technology has a Altman Z2-Score of 1.86 indicating it is in Grey Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 1.86 mean?
Mediwelcome Healthcare Management & Technology (HKSE:02159) has a Altman Z2-Score of 1.86 as of Jul. 22, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Mediwelcome Healthcare Management & Technology and its competitors. This is 62% below median its historical median of 4.85. According to the industry distribution chart, Mediwelcome Healthcare Management & Technology ranks #364 out of 674 companies in the Healthcare Providers & Services industry, placing it in the top 54%.
Is Mediwelcome Healthcare Management & Technology's Altman Z2-Score too high?
Mediwelcome Healthcare Management & Technology's current Altman Z2-Score of 1.86 is 62% below median its 10-year median of 4.85. The Healthcare Providers & Services industry median Altman Z2-Score is 2.22. Mediwelcome Healthcare Management & Technology's value of 1.86 is 16.2% below this industry median. Based on the distribution chart, Mediwelcome Healthcare Management & Technology ranks #364 out of 674 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Mediwelcome Healthcare Management & Technology has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mediwelcome Healthcare Management & Technology's Altman Z2-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Mediwelcome Healthcare Management & Technology ranks #364 out of 674 companies for Altman Z2-Score. This places Mediwelcome Healthcare Management & Technology in the lower half of its industry. The industry median Altman Z2-Score is 2.22. Mediwelcome Healthcare Management & Technology's value of 1.86 is 16.2% below this benchmark. While the company's 10-year median is 4.85 vs. the industry median of 2.22, Mediwelcome Healthcare Management & Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Healthcare Providers & Services company?
The median Altman Z2-Score among Healthcare Providers & Services companies is 2.22, based on 674 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mediwelcome Healthcare Management & Technology's current Altman Z2-Score of 1.86 is 16.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Mediwelcome Healthcare Management & Technology and its competitors. For the Healthcare Providers & Services industry, the median Altman Z2-Score is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mediwelcome Healthcare Management & Technology's current Altman Z2-Score is 1.86, which is 62% below median its own 10-year median of 4.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mediwelcome Healthcare Management & Technology stock overvalued right now?
Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology (HKSE:02159) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.70, compared to a current price of HK$1.62 — trading 131.4% above its estimated fair value. The current Altman Z2-Score is 1.86, which is 62% below median its 10-year median of 4.85 and 16.2% below the Healthcare Providers & Services industry median of 2.22. Mediwelcome Healthcare Management & Technology's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Mediwelcome Healthcare Management & Technology (HKSE:02159), the current Altman Z2-Score is 1.86 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mediwelcome Healthcare Management & Technology (HKSE:02159) Overvalued in 2026?

Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology stock appears to be overvalued. The current stock price of HK$1.62 is trading 131.4% above its estimated GF Value™ of HK$0.70. GuruFocus considers Mediwelcome Healthcare Management & Technology to be Significantly Overvalued.

Key valuation signals for HKSE:02159:

  • Altman Z2-Score: 1.86 (62% below median its 10-year median of 4.85)
  • GF Value™: HK$0.70 vs. price of HK$1.62 (131.4% above fair value)
  • GF Score™: 54/100 with 4 warning signs
  • Industry Position: 16.2% below the Healthcare Providers & Services median (#364 of 674)

No single metric tells the full story. See the HKSE:02159 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mediwelcome Healthcare Management & Technology Business Description

Address Wangjingdongyuan Zone 4, Wangjing East Park, 17th Floor, Block B, Greenland Center, Chaoyang District, Beijing, CHN, 100101
Mediwelcome Healthcare Management & Technology Inc is an investment holding company. The Group mainly provides medical conference services, patient education and screening services, and marketing and consulting services, in addition to providing integrated healthcare marketing solutions. Its products and services include Academic Conference Management System, Scientific Research Data Reporting System, the Health/Medical Media Matrix, patient management services, and marketing and consulting services. The Group has only one reportable segment, mainly operating its businesses in the PRC and earning revenue from the PRC.
54GF Score

Get the complete analysis for HKSE:02159

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.62
Price
HK$0.70
GF Value